chronic hepatitis B vaccine (Nanjing Huawe)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namechronic hepatitis B vaccine (Nanjing Huawe)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Huawe Medicine Technology Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Huawe Medicine Technology Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A